Literature DB >> 24220189

Near full-length genome analysis of HCV genotype 5 strains from South Africa.

Maemu P Gededzha1, Selokela G Selabe2, Jason T Blackard3, Thanda Kyaw4, M Jeffrey Mphahlele5.   

Abstract

Hepatitis C virus (HCV) genotype 5 is the predominant genotype in South Africa. However, to date, only 2 full-length genotype 5 genomes have been sequenced and only one is from South Africa. This study characterized HCV genotype 5 sequences from South Africa, including six near full-length genomes, as well as the E1 region from an additional 12 genotype 5 samples. Phylogenetic analysis of these near full-length genome sequences revealed that all genotype 5 sequences formed a close cluster with high bootstrap support. Bayesian analysis of the E1 region was used to estimate the time of the most recent common ancestor (tMRCA). The tMRCA for HCV genotype 5a was estimated at 114-134 years before the last sampling date. In conclusion, this study provides six near full-length genotype 5 nucleotide sequences for use as references to design efficient vaccines and for the development of new antiviral agents, and provides further insight into the diversity of HCV genotypes circulating in South Africa.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bayesian coalescent; HCV genotype 5a; Near full-length

Mesh:

Year:  2013        PMID: 24220189     DOI: 10.1016/j.meegid.2013.10.022

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  6 in total

Review 1.  Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.

Authors:  Simona Ruta; Costin Cernescu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

2.  Prediction of T-cell epitopes of hepatitis C virus genotype 5a.

Authors:  Maemu P Gededzha; M Jeffrey Mphahlele; Selokela G Selabe
Journal:  Virol J       Date:  2014-11-08       Impact factor: 4.099

3.  Characterization of HCV genotype 5a envelope proteins: implications for vaccine development and therapeutic entry target.

Authors:  Maemu Petronella Gededzha; Maphahlanganye Jeffrey Mphahlele; Selokela Gloria Selabe
Journal:  Hepat Mon       Date:  2014-11-22       Impact factor: 0.660

4.  Molecular epidemiology of hepatitis C virus in Cambodia during 2016-2017.

Authors:  Janin Nouhin; Momoko Iwamoto; Sophearot Prak; Jean-Philippe Dousset; Kerya Phon; Seiha Heng; Alexandra Kerleguer; Mickaël Le Paih; Philippe Dussart; David Maman; François Rouet
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

5.  Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study.

Authors:  Lynnette Bhebhe; Motswedi Anderson; Sajini Souda; Wonderful T Choga; Edward Zumbika; Zachary M Shaver; Tshepiso Mbangiwa; Bonolo B Phinius; Chabeni C Banda; Pinkie Melamu; Rosemary M Musonda; Max Essex; Jason T Blackard; Sikhulile Moyo; Simani Gaseitsiwe
Journal:  BMC Infect Dis       Date:  2019-10-22       Impact factor: 3.090

6.  Comparison of Three Different Hepatitis C Virus Genotyping Methods: 5'NCR PCR-RFLP, Core Type-Specific PCR, and NS5b Sequencing in a Tertiary Care Hospital in South India.

Authors:  Hubert D-J Daniel; Joel David; Sukanya Raghuraman; Manu Gnanamony; George M Chandy; Gopalan Sridharan; Priya Abraham
Journal:  J Clin Lab Anal       Date:  2016-09-01       Impact factor: 2.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.